2021 Insights on COVID-19 Vaccines – Opportunity Assessment and Forecast to 2026 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Coronavirus Disease 2019 (COVID-19) Vaccines – Opportunity Assessment and Forecast to 2026” report has been added to ResearchAndMarkets.com’s offering.

This report gives a COVID-19 disease overview, epidemiology overview, current marketed vaccines, unmet needs, pipeline assessment, and market outlook.

The publisher forecasts three different potential scenarios for the future use of COVID-19 vaccines:

• The first scenario assumes that annual vaccination with a COVID-19 vaccine will be needed.
• The second scenario assumes annual vaccination for the high-risk population of people 65 years of age and older, while everyone below 65 years of age will need a vaccine only every two years.
• In the third scenario, the high-risk population of people 65 years of age and older will receive a COVID-19 vaccine every two years, while everyone below 65 years will need a vaccine only every five years.

Companies Mentioned

• Pfizer
• BioNTech
• Moderna
• AstraZeneca
• Johnson & Johnson
• Novavax
• CureVac
• Sanofi
• GlaxoSmithKline
• Arcturus
• Medicago
• Valneva
• Inovio

This report includes:

• Executive Summary
• Disease Overview: History of the outbreak, Etiology and Pathophysiology
• Epidemiology
• Current Vaccination Options: Includes detailed product profiles with SWOT analysis
• Unmet Need and Opportunities: Detailing the major unmet needs with significant KOL insights
• Pipeline Assessment: Includes pipeline overview and detailed product profiles with SWOT analysis
• R&D Strategies: Trends in Clinical Trial Design for COVID-19 Vaccines and Trends in Deal-Making
• Market Outlook

Reasons to Buy

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving the 7MM COVID-19 vaccine.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global COVID-19 vaccine market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.

Key Topics Covered:

1. Executive Summary

2. Disease Overview

3. Epidemiology

4. Current Vaccination Options

5. Unmet Needs and Opportunities

6. Pipeline Assessment

7. R&D Strategies

8. Market Outlook

9. Appendix

10. Contact the Publisher

For more information about this report visit https://www.researchandmarkets.com/r/an2xjw.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]

For E.S.T. Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900